Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-08-22

Clinical Trial Update: Therapy Optimisation for the Treatment of Hairy Cell Leukemia [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update for therapy optimisation in hairy cell leukemia is in Phase 2/3 and currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Giessen | Conditions: Hairy Cell Leukemia | Phase 2, Phase 3 | Status: RECRUITING